These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27611498)

  • 1. Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model.
    Hosokawa K; Ohnishi-Wada T; Sameshima-Kaneko H; Nagasato T; Miura N; Kikuchi K; Koide T; Maruyama I; Urano T
    Thromb Res; 2016 Oct; 146():69-75. PubMed ID: 27611498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
    Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
    Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.
    Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF
    Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life.
    Jankun J; Aleem AM; Struniawski R; Lysiak-Szydłowska W; Selman SH; Skrzypczak-Jankun E
    Pharmacol Rep; 2009; 61(4):673-80. PubMed ID: 19815949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
    Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
    Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.
    Ogawa S; Szlam F; Dunn AL; Bolliger D; Ohnishi T; Hosokawa K; Tanaka KA
    Haemophilia; 2012 Nov; 18(6):926-32. PubMed ID: 22642581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic Modeling of Thrombolysis.
    Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis.
    Levi M; Biemond BJ; van Zonneveld AJ; ten Cate JW; Pannekoek H
    Circulation; 1992 Jan; 85(1):305-12. PubMed ID: 1728462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1.
    Nicholls SC; Hoffer EK; Chandler WL
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):729-33. PubMed ID: 14614351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
    Stringer HA; van Swieten P; Heijnen HF; Sixma JJ; Pannekoek H
    Arterioscler Thromb; 1994 Sep; 14(9):1452-8. PubMed ID: 8068607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo.
    Vaughan DE; Declerck PJ; Van Houtte E; De Mol M; Collen D
    Thromb Haemost; 1992 Jul; 68(1):60-3. PubMed ID: 1514173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.
    Shohet RV; Spitzer S; Madison EL; Bassel-Duby R; Gething MJ; Sambrook JF
    Thromb Haemost; 1994 Jan; 71(1):124-8. PubMed ID: 8165630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents.
    Huber K
    J Thromb Thrombolysis; 2001 May; 11(3):195-202. PubMed ID: 11577257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
    Fay WP; Eitzman DT; Shapiro AD; Madison EL; Ginsburg D
    Blood; 1994 Jan; 83(2):351-6. PubMed ID: 8286735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
    Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
    Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.